The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC).
Pamela Jean Goodwin
No relevant relationships to disclose
Wendy Parulekar
No relevant relationships to disclose
Karen A. Gelmon
No relevant relationships to disclose
Lois E. Shepherd
No relevant relationships to disclose
Jennifer A. Ligibel
No relevant relationships to disclose
Dawn L. Hershman
No relevant relationships to disclose
Priya Rastogi
No relevant relationships to disclose
Ingrid A. Mayer
No relevant relationships to disclose
Timothy J. Hobday
No relevant relationships to disclose
Julie Lemieux
No relevant relationships to disclose
Alastair Mark Thompson
Research Funding - Cancer Research UK
Kathleen I. Pritchard
No relevant relationships to disclose
Timothy Joseph Whelan
No relevant relationships to disclose
Som Dave Mukherjee
No relevant relationships to disclose
Haji I. Chalchal
No relevant relationships to disclose
Conrad D. Oja
No relevant relationships to disclose
Katia Sonia Tonkin
No relevant relationships to disclose
Vanessa Bernstein
No relevant relationships to disclose
Bingshu E Chen
No relevant relationships to disclose
Vuk Stambolic
No relevant relationships to disclose